ENTRY       D07423                      Drug
NAME        Defibrotide sodium (JAN/USAN);
            Defitelio (TN)
PRODUCT     DEFITELIO (Jazz Pharmaceuticals)
REMARK      Therapeutic category: 3919
            ATC code: B01AX01
            Product: D07423<JP/US>
EFFICACY    Antithrombotic, Thrombogenesis factor regulator
COMMENT     Polydeoxyribonucleotides from bovine lung or other mammalian organs with molecular weight between 15,000 and 30,000.
            Treatment of hepatic veno-occlusive disease
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             B BLOOD AND BLOOD FORMING ORGANS
              B01 ANTITHROMBOTIC AGENTS
               B01A ANTITHROMBOTIC AGENTS
                B01AX Other antithrombotic agents
                 B01AX01 Defibrotide
                  D07423  Defibrotide sodium (JAN/USAN) &lt;JP/US&gt;
            Therapeutic category of drugs in Japan [BR:br08301]
             3  Agents affecting metabolism
              39  Other agents affecting metabolism
               391  Liver disease agents
                3919  Others
                 D07423  Defibrotide sodium (JAN/USAN)
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D07423
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D07423
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D07423
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D07423
DBLINKS     CAS: 83712-60-1
            PubChem: 51091757
///
